These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26365020)

  • 1. Development of albumin-based nanoparticles for the delivery of abacavir.
    Wilson B; Paladugu L; Priyadarshini SR; Jenita JJ
    Int J Biol Macromol; 2015 Nov; 81():763-7. PubMed ID: 26365020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles based on albumin: preparation, characterization and the use for 5-flurouracil delivery.
    Wilson B; Ambika TV; Patel RD; Jenita JL; Priyadarshini SR
    Int J Biol Macromol; 2012 Dec; 51(5):874-8. PubMed ID: 22820011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and optimization of doxorubicin-loaded albumin nanoparticles using response surface methodology.
    Li L; Zhao X; Yang C; Hu H; Qiao M; Chen D
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1170-80. PubMed ID: 21449822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin micro/nanoparticles entrapping liposomes for itraconazole green formulation.
    de Jesús Valle MJ; Maderuelo Martín C; Zarzuelo Castañeda A; Sánchez Navarro A
    Eur J Pharm Sci; 2017 Aug; 106():159-165. PubMed ID: 28577996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-stablized bovine serum albumin nanoparticles having ability to control the release of NELL-1 protein.
    Li Y; Song H; Xiong S; Tian T; Liu T; Sun Y
    Int J Biol Macromol; 2018 Apr; 109():672-680. PubMed ID: 29288032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of chitosan-based nanoparticles through inter-polymeric complexation for oral drug delivery.
    Jana S; Maji N; Nayak AK; Sen KK; Basu SK
    Carbohydr Polym; 2013 Oct; 98(1):870-6. PubMed ID: 23987423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
    Battogtokh G; Kang JH; Ko YT
    Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the release process and modelling of in vitro release data of cis-dichlorodiamminoplatinum (II) encapsulated into poly(2-hydroxyethyl methacrylate) nanocarriers.
    Gupta MK; Bajpai J; Bajpai AK
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():852-62. PubMed ID: 26478380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of albumin based nanoparticles for delivery of fisetin and evaluation of its cytotoxic activity.
    Ghosh P; Singha Roy A; Chaudhury S; Jana SK; Chaudhury K; Dasgupta S
    Int J Biol Macromol; 2016 May; 86():408-17. PubMed ID: 26820351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.
    Gan Q; Wang T
    Colloids Surf B Biointerfaces; 2007 Sep; 59(1):24-34. PubMed ID: 17555948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery.
    Varshosaz J; Hassanzadeh F; Mardani A; Rostami M
    Pharm Dev Technol; 2015 Mar; 20(2):183-96. PubMed ID: 24219091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox responsive albumin autogenic nanoparticles for the delivery of cancer drugs.
    Thirupathi Kumara Raja S; Prakash T; Gnanamani A
    Colloids Surf B Biointerfaces; 2017 Apr; 152():393-405. PubMed ID: 28157647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug loading and release on tumor cells using silk fibroin-albumin nanoparticles as carriers.
    Subia B; Kundu SC
    Nanotechnology; 2013 Jan; 24(3):035103. PubMed ID: 23262833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication and evaluation of nanoparticle-assembled BSA microparticles for enhanced liver delivery of glycyrrhetinic acid.
    Wang W; Lei Y; Sui H; Zhang W; Zhu R; Feng J; Wang H
    Artif Cells Nanomed Biotechnol; 2017 Jun; 45(4):740-747. PubMed ID: 27267996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of albumin nanoparticles for the delivery of a novel β-tubulin polymerization inhibitor.
    Spada A; Emami J; Sanaee F; Aminpour M; Paiva IM; Tuszynski J; Lavasanifar A
    J Pharm Pharm Sci; 2021; 24():344-362. PubMed ID: 34224665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of DOX/BSANP and its antitumor effect on bel-7404 liver cancer cells in vitro and in vivo.
    Miao FQ; An YL; Yang R; Tang QS; Zhang JQ
    Biomed Mater Eng; 2014; 24(1):599-607. PubMed ID: 24211944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration.
    Mathew ST; Devi SG; KV S
    AAPS PharmSciTech; 2007 Feb; 8(1):14. PubMed ID: 17408214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of novel composite alginate chitosan-carrageenan nanoparticles for encapsulation of BSA as a model drug delivery system.
    Cheng L; Bulmer C; Margaritis A
    Curr Drug Deliv; 2015; 12(3):351-7. PubMed ID: 26054536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of Curcumin Loaded Egg Albumin Nanoparticles Using Acetone and Optimization of Desolvation Process.
    Aniesrani Delfiya DS; Thangavel K; Amirtham D
    Protein J; 2016 Apr; 35(2):124-35. PubMed ID: 26960679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and characterization of albumin microspheres containing norcantharidate for liver tumor targeting.
    Yan F; Li B; Shen F; Fu Q
    Drug Deliv; 2015; 22(6):862-8. PubMed ID: 24670098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.